acetylglucosamine has been researched along with Disease Exacerbation in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 5 (18.52) | 29.6817 |
| 2010's | 15 (55.56) | 24.3611 |
| 2020's | 5 (18.52) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Z; Han, W; Han, X; Herzog, RI; Jiang, M; Kaech, S; Lee, JS; Lee, P; Li, MD; Ni, W; Nie, Y; Ong, Q; Qian, K; Ruan, HB; Sherwin, RS; Singh, JP; Singh, K; Wendel, HG; Wu, J; Yang, X; Yates, JR; Zhang, B; Zhang, K; Zhou, J | 1 |
| Asahi, M; Higuchi, K; Moriwaki, K; Takeuchi, T; Ueda, Y | 1 |
| Nakayama, J; Okumura, M; Uehara, T; Yamanoi, K | 1 |
| Fujita, H; Kato, S; Morii, T; Nara, M; Otomo, H; Sato, T; Shimizu, T; Suganuma, Y; Yamada, Y | 1 |
| Agopian, J; Asara, JM; Brenet, F; Castellano, R; Chelbi, R; Da Costa, Q; De Sepulveda, P; Dubreuil, P; Goubard, A; Hermine, O; Kousteridou, P; Maurizio, J; Nguyen, QV; Orfao, A; Scorrano, G; Teodosio, C; Yuan, M | 1 |
| Fujii, C; Nakayama, J; Ohya, A; Shimojo, H; Yamanoi, K | 1 |
| Katakami, N | 1 |
| da Costa Rodrigues, B; de Queiroz, RM; Dias, WB; Todeschini, AR; Vasconcelos-Dos-Santos, A | 1 |
| Dai, W; Fang, L; Gu, J; Song, S; Wang, J; Wang, Y; Wu, W; Yang, T; Zheng, X | 1 |
| Dai, Y; Fan, X; Gao, S; Lin, Y; Liu, X; Liu, Y; Miao, Y; Qian, P; Xia, L; Zhou, J; Zhu, J; Zhu, P | 1 |
| Lam, C; Phillips, RM; Tran, PT; Wang, H | 1 |
| Betesh, LR; Brooks, J; Burch, TC; Drake, RR; Jones, EE; Lance, RS; Mehta, A; Nyalwidhe, JO; Powers, TW; Semmes, OJ; Troyer, DA; Watson, MT; White, KY | 1 |
| Arakura, N; Hasebe, O; Iwaya, Y; Kitahara, K; Koide, N; Muraki, T; Nakayama, J; Shinji, A; Suga, T; Tanaka, E; Yamada, S; Yokosawa, S | 1 |
| Conradt, HS; Costa, J; de Carvalho, M; Gonçalves, M; Pinto, S; Tillack, L | 1 |
| Chen, X; Zhang, N | 1 |
| Arasu, UT; Deen, AJ; Hassinen, A; Kärnä, R; Kellokumpu, S; Oikari, S; Pasonen-Seppänen, S; Rilla, K; Takabe, P; Tammi, M; Tammi, R; Wojciechowski, S | 1 |
| Guven, Z; Ozkan, FU; Ozkan, K; Ramadan, S | 1 |
| Aglipay, JA; Bernstein, JD; Goswami, S; Song, Y; Stanley, P | 1 |
| Lefebvre, T; Michalski, JC; Mir, AM; Olivier, S | 1 |
| Bonaccini, L; Marini, M; Parretti, E; Sgambati, E; Thyrion, GD; Vichi, D | 1 |
| Alvarez, R; Cummings, RD; Miwa, HE; Song, Y; Stanley, P | 1 |
| Chabás, A; Coll, MJ; Fernández-Herrera, JM; García-Díez, A; Sánchez-Pérez, J; Vargas-Díez, E | 1 |
| Rogler, CE; Stanley, P; Tang, J; Yang, X | 1 |
| Ishibashi, Y; Itakura, T; Itoh, K; Kuroki, A; Kuwahara, J; Tsuji, D; Yamanaka, S | 1 |
| Arvio, M; Arvio, P; Hurmerinta, K; Pirinen, S; Sillanpää, M | 1 |
| Autti, T; Ginns, EI; Ikonen, S; Jalanko, A; Joensuu, R; LaMarca, ME; Manninen, T; McKinney, CE; Peltonen, L; Rapola, J; Riekkinen, P; Sipilä, I; Tenhunen, K | 1 |
| Bhaumik, M; Guttenplan, J; Harris, T; Johnson, L; Rogler, C; Stanley, P; Sundaram, S | 1 |
5 review(s) available for acetylglucosamine and Disease Exacerbation
| Article | Year |
|---|---|
Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus.
Topics: Acetylglucosamine; Animals; Arteries; Atherosclerosis; Cardiovascular Diseases; Diabetes Complications; Disease Progression; Dyslipidemias; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypertension; Inflammation; Insulin Resistance; Mice; Muscle, Smooth, Vascular; Obesity; Oxidative Stress; Polymers; Protein Kinase C; Quality of Life; Reactive Oxygen Species; Risk Factors | 2018 |
Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.
Topics: Acetylglucosamine; Animals; Disease Progression; Glycosylation; Humans; Hyperglycemia; Neoplasms | 2018 |
Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
Topics: Acetylglucosamine; Biosynthetic Pathways; Cell Transformation, Neoplastic; Disease Progression; Epithelial-Mesenchymal Transition; Glycosylation; Hexosamines; Humans; Neoplasms | 2019 |
The bisecting GlcNAc in cell growth control and tumor progression.
Topics: Acetylglucosamine; Animals; Cell Proliferation; Disease Progression; Galectins; Humans; Intercellular Signaling Peptides and Proteins; N-Acetylglucosaminyltransferases; Neoplasms; Signal Transduction | 2012 |
Angiokeratoma corporis diffusum in a Spanish patient with aspartylglucosaminuria.
Topics: Acetylglucosamine; Adult; Aspartylglucosaminuria; Disease Progression; Fabry Disease; Female; Follow-Up Studies; Humans; Macroglossia; Skin Diseases, Genetic | 2002 |
22 other study(ies) available for acetylglucosamine and Disease Exacerbation
| Article | Year |
|---|---|
O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth.
Topics: Acetylation; Acetylglucosamine; Animals; Antigens, Neoplasm; Carrier Proteins; Cell Line, Tumor; Datasets as Topic; Disease Progression; Female; Gene Expression Profiling; Glycolysis; HEK293 Cells; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Male; Membrane Proteins; Mice; N-Acetylglucosaminyltransferases; Neoplasm Grading; Neoplasm Staging; Neoplasms; Protein Processing, Post-Translational; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Tissue Array Analysis; Up-Regulation; Xenograft Model Antitumor Assays | 2020 |
O-GlcNAcylation-mediated degradation of FBXL2 stabilizes FOXM1 to induce cancer progression.
Topics: Acetylglucosamine; Acylation; Cell Line, Tumor; Cell Proliferation; Disease Progression; F-Box Proteins; Forkhead Box Protein M1; Humans; Protein Stability; Proteolysis; Stomach Neoplasms; Ubiquitination | 2020 |
Decreased alpha-1,4-linked N-acetylglucosamine glycosylation in biliary tract cancer progression from biliary intraepithelial neoplasia to invasive adenocarcinoma.
Topics: Acetylglucosamine; Adenocarcinoma; Biliary Tract; Biliary Tract Neoplasms; Carcinoma in Situ; Disease Progression; Glycosylation; Humans; Immunohistochemistry; Mucin 5AC; Mucin-6; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Proteins | 2020 |
Sodium-glucose cotransporter 2 inhibition attenuates protein overload in renal proximal tubule via suppression of megalin O-GlcNacylation in progressive diabetic nephropathy.
Topics: Acetylglucosamine; Acylation; Animals; Diabetic Nephropathies; Disease Progression; Kidney Tubules, Proximal; Low Density Lipoprotein Receptor-Related Protein-2; Male; Mice; Mice, Inbred C57BL; Proteins; Sodium-Glucose Transporter 2 | 2020 |
GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness.
Topics: Acetylglucosamine; Adult; Animals; Chromatin Assembly and Disassembly; Disease Progression; Humans; Mast Cells; Mastocytosis, Systemic; Metabolome; Mice, SCID; Prospective Studies | 2021 |
Gastric gland mucin-specific O-glycan expression decreases with tumor progression from precursor lesions to pancreatic cancer.
Topics: Acetylglucosamine; Biomarkers, Tumor; Carbohydrate Conformation; Carcinogenesis; Carcinoma, Pancreatic Ductal; Disease Progression; Gastric Mucosa; Glycosylation; Humans; Mucin 5AC; Mucin-6; Pancreatic Neoplasms; Precancerous Conditions; Protein Processing, Post-Translational | 2017 |
O-GlcNAcylation on Rab3A attenuates its effects on mitochondrial oxidative phosphorylation and metastasis in hepatocellular carcinoma.
Topics: Acetylglucosamine; Adult; Animals; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Hydrogen Peroxide; Immunohistochemistry; Immunoprecipitation; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitochondria; Oxidative Phosphorylation; Oxygen Consumption; rab3A GTP-Binding Protein; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Superoxides | 2018 |
Reciprocal Regulation Between O-GlcNAcylation and β-Catenin Facilitates Cell Viability and Inhibits Apoptosis in Liver Cancer.
Topics: Acetylglucosamine; Apoptosis; beta Catenin; Carcinogenesis; Cell Survival; Disease Progression; Hep G2 Cells; Humans; Liver Neoplasms; Nucleotidyltransferases; Up-Regulation | 2019 |
Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.
Topics: Acetylglucosamine; Disease Progression; Glycomics; Glycoproteins; Humans; Male; Neoplasm Grading; Polysaccharides; Prostate; Prostatic Neoplasms | 2013 |
Reduced expression of αGlcNAc in Barrett's oesophagus adjacent to Barrett's adenocarcinoma--a possible biomarker to predict the malignant potential of Barrett's oesophagus.
Topics: Acetylglucosamine; Adenocarcinoma; Aged; Aged, 80 and over; Animals; Barrett Esophagus; Biomarkers, Tumor; Case-Control Studies; CDX2 Transcription Factor; Disease Progression; Esophageal Neoplasms; Female; Homeodomain Proteins; Humans; Immunohistochemistry; Male; Mice; Middle Aged; Mucin-6; Polysaccharides | 2014 |
Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis.
Topics: Acetylglucosamine; Adult; Aged; Amyotrophic Lateral Sclerosis; Biomarkers; Case-Control Studies; Chromatography, Liquid; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Fucose; Glycomics; Glycosylation; Humans; Male; Mass Spectrometry; Middle Aged; Neurofilament Proteins; Phosphoproteins; Polysaccharides; Sialic Acids | 2015 |
Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
Topics: Acetylglucosamine; beta-N-Acetylhexosaminidases; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromones; Disease Progression; Enzyme Inhibitors; Gene Silencing; Humans; Morpholines; N-Acetylglucosaminyltransferases; Neoplasm Invasiveness; Oncogenes; Phenotype; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Serine; Signal Transduction; Stomach Neoplasms; Up-Regulation | 2016 |
UDP-sugar substrates of HAS3 regulate its O-GlcNAcylation, intracellular traffic, extracellular shedding and correlate with melanoma progression.
Topics: Acetylglucosamine; Acylation; Animals; Cell Line; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Disease Progression; Endocytosis; Glucuronosyltransferase; Humans; Hyaluronan Synthases; Hyaluronic Acid; Melanoma; Protein Transport; Skin; Skin Neoplasms; Uridine Diphosphate N-Acetylglucosamine; Uridine Diphosphate Sugars | 2016 |
Chondroprotective effect of N-acetylglucosamine and hyaluronate in early stages of osteoarthritis--an experimental study in rabbits.
Topics: Acetylglucosamine; Animals; Anterior Cruciate Ligament; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Hyaluronic Acid; Injections, Intra-Articular; Injections, Intramuscular; Knee Joint; Osteoarthritis, Knee; Rabbits; Range of Motion, Articular; Time Factors | 2009 |
The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression.
Topics: Acetylglucosamine; Animals; CHO Cells; Cricetinae; Cricetulus; Disease Progression; Dystroglycans; Female; Intercellular Signaling Peptides and Proteins; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred C57BL; Mice, Transgenic; N-Acetylglucosaminyltransferases; Neoplasm Metastasis; Polysaccharides; Signal Transduction | 2010 |
[Signaling and metabolic predispositions linked to the colorectal cancer].
Topics: Acetylglucosamine; Adenocarcinoma; beta Catenin; Colorectal Neoplasms; Diet; Disease Progression; Disease Susceptibility; Energy Metabolism; Genes, p53; Genes, Tumor Suppressor; Glycosylation; Humans; Insulin Resistance; Intestinal Mucosa; Metabolic Syndrome; Models, Biological; Oncogenes; Protein Processing, Post-Translational; Receptor Protein-Tyrosine Kinases; Risk Factors; Signal Transduction; Wnt Proteins | 2011 |
Distribution of sugar residues in human placentas from pregnancies complicated by hypertensive disorders.
Topics: Acetylgalactosamine; Acetylglucosamine; Adult; Carbohydrates; Disease Progression; Female; Galactose; Glucose; HELLP Syndrome; Humans; Lectins; Mannose; Placenta; Pre-Eclampsia; Pregnancy | 2011 |
Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III.
Topics: Acetylglucosamine; Animals; Apoptosis; Carbohydrate Sequence; Carcinogens; Cell Division; Diethylnitrosamine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Glycoproteins; Hepatectomy; Hepatocytes; Liver Neoplasms, Experimental; Liver Regeneration; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Molecular Sequence Data; N-Acetylglucosaminyltransferases; Phenobarbital; Vascular Endothelial Growth Factor A | 2003 |
Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates.
Topics: Acetylglucosamine; Animals; Astrocytes; beta-N-Acetylhexosaminidases; Brain; Calcium-Binding Proteins; Chemokine CCL3; Chemokine CCL4; Chemokines; Disease Models, Animal; Disease Progression; G(M2) Ganglioside; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glycoconjugates; Hexosaminidase A; Hexosaminidase B; Macrophage Inflammatory Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Microfilament Proteins; Microglia; Neuroglia; Protein Subunits; RNA, Messenger; Sandhoff Disease; Up-Regulation | 2005 |
Reduction in head size in patients with aspartylglucosaminuria.
Topics: Acetylglucosamine; Adolescent; Adult; Aged; Aspartylglucosaminuria; Aspartylglucosylaminase; Cephalometry; Child; Child, Preschool; Dementia; Disease Progression; Female; Follow-Up Studies; Humans; Lysosomal Storage Diseases; Male; Microcephaly; Reference Values | 2005 |
Mice with an aspartylglucosaminuria mutation similar to humans replicate the pathophysiology in patients.
Topics: Acetylglucosamine; Animals; Aspartylglucosaminuria; Aspartylglucosylaminase; Brain; Disease Models, Animal; Disease Progression; Gene Targeting; Genes, Recessive; Humans; Intellectual Disability; Liver; Lysosomal Storage Diseases; Magnetic Resonance Imaging; Maze Learning; Mice; Mice, Knockout; Microscopy, Electron; Phenotype | 1998 |
Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression.
Topics: Acetylglucosamine; Animals; Carcinogens; Diethylnitrosamine; Disease Progression; Female; Genetic Vectors; Liver Neoplasms, Experimental; Male; Mice; N-Acetylglucosaminyltransferases; Neoplasm Proteins; Phenobarbital; Polysaccharides | 1998 |